Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M López-Vega

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Seminars in Oncology|February 1, 1991
Phase II study of carboplatin in advanced breast cancer: preliminary resultsM Martin, E Diaz-Rubio, A Casado, et al.
Acta Neurologica Scandinavica|January 1, 1988
Motor neuron disease in CantabriaJ M López-Vega, J Calleja, O Combarros, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
The natural course of emesis after carboplatin treatmentM Martin, E Diaz-Rubio, A Sánchez, et al.
Investigational New Drugs|January 1, 1994
Phase I study of mitonafide with a 3-day administration schedule: early interruption due to severe central nervous system toxicityE Díaz-Rubio, M Martín, J M López-Vega, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 3, 2025
Personalized recurrence risk prediction in early-stage breast cancer through an integrative mathematical model based on MammaPrint®, radiotherapy, phenotype, and clinicopathological factorsJ Sánchez Mazón, A de Juan Ferré, J M López Vega, et al.
American Journal of Clinical Oncology|August 1, 1992
Intravenous and oral magnesium supplementations in the prophylaxis of cisplatin-induced hypomagnesemia. Results of a controlled trialM Martin, E Diaz-Rubio, A Casado, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Carboplatin: an active drug in metastatic breast cancerM Martín, E Díaz-Rubio, A Casado, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Ifosfamide in advanced epidermoid head and neck cancerM Martín, E Diaz-Rubio, J L González Larriba, et al.
Breast Cancer Research and Treatment|February 27, 2003
Sequential doxorubicin and docetaxel as first-line treatment in metastatic breast cancer: a GEICAM-9801 phase II studyE Alba, N Ribelles, A Antón, et al.
Journal of Surgical Oncology|March 1, 1994
Central venous brachial catheter (P.A.S. Port TM) and catheter scanning system (Cath-Finder TM)M C Carré, J M López Vega, J Carles, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Seminars in Oncology|February 1, 1991
Phase II study of carboplatin in advanced breast cancer: preliminary resultsM Martin, E Diaz-Rubio, A Casado, et al.
Acta Neurologica Scandinavica|January 1, 1988
Motor neuron disease in CantabriaJ M López-Vega, J Calleja, O Combarros, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
The natural course of emesis after carboplatin treatmentM Martin, E Diaz-Rubio, A Sánchez, et al.
Investigational New Drugs|January 1, 1994
Phase I study of mitonafide with a 3-day administration schedule: early interruption due to severe central nervous system toxicityE Díaz-Rubio, M Martín, J M López-Vega, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 3, 2025
Personalized recurrence risk prediction in early-stage breast cancer through an integrative mathematical model based on MammaPrint®, radiotherapy, phenotype, and clinicopathological factorsJ Sánchez Mazón, A de Juan Ferré, J M López Vega, et al.
American Journal of Clinical Oncology|August 1, 1992
Intravenous and oral magnesium supplementations in the prophylaxis of cisplatin-induced hypomagnesemia. Results of a controlled trialM Martin, E Diaz-Rubio, A Casado, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Carboplatin: an active drug in metastatic breast cancerM Martín, E Díaz-Rubio, A Casado, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Ifosfamide in advanced epidermoid head and neck cancerM Martín, E Diaz-Rubio, J L González Larriba, et al.
Breast Cancer Research and Treatment|February 27, 2003
Sequential doxorubicin and docetaxel as first-line treatment in metastatic breast cancer: a GEICAM-9801 phase II studyE Alba, N Ribelles, A Antón, et al.
Journal of Surgical Oncology|March 1, 1994
Central venous brachial catheter (P.A.S. Port TM) and catheter scanning system (Cath-Finder TM)M C Carré, J M López Vega, J Carles, et al.
Pageof 2